Literature DB >> 22546644

Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients.

Hassan Argani1, Amir Ghorbanihaghjo, Ghodratollah Panahi, Nadereh Rashtchizadeh, Javid Safa, Saeed Mahmoudi Meimand.   

Abstract

OBJECTIVE: The aim of the present study was to evaluate of Fetuin-A and Pentraxin3 (PTX3) as the main factors for vascular calcification and inflammation in hemodialysis (HD) and renal transplant (RT) patients.
METHOD: Serum was obtained from 45 stable chronic HD patients and 44 stable RT recipients. Biochemical factors, intact Parathormone, high-sensitive C-reactive protein (hsCRP), Fetuin-A and PTX3 levels were determined by standard methods.
RESULTS: In the RT recipients PTX3 level was significantly higher than the HD patients [5.78(1.09-20.36) ng/mL vs. 1.65(0.24-7.89) ng/mL, p ≤ 0.001]. Serum Fetuin-A concentration was significantly higher in the HD compared to RT group [43.39(27.75-81.48) ng/mL vs. 38.76(22.26-89.07) ng/mL, p=0.020]. hsCRP level was also higher in the HD than the RT group [2.90(0.1-8.50) mg/L vs. 1.1(0.1-7.9) mg/L, p=0.003].
CONCLUSION: Although our study shows that serum PTX3 is increased and Fetuin-A is decreased after successful RT, their direct role on atherosclerosis needs further studies in the future.
Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22546644     DOI: 10.1016/j.clinbiochem.2012.04.011

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

1.  Pentraxin-3: A new parameter in predicting the severity of diabetic foot infection?

Authors:  Safak Ozer Balin; Ayse Sagmak Tartar; Kader Uğur; Faruk Kilinç; Selda Telo; Ali Bal; Mehmet Balin; Ayhan Akbulut
Journal:  Int Wound J       Date:  2019-02-15       Impact factor: 3.315

2.  Association of genetic variants of pentraxin 3 rs3816527 with hypertension in Chronic kidney disease patients.

Authors:  Eman A E Badr; Ghada E Hamoda; Safaa I Tayel; Elsayed I Elshayeb
Journal:  Mol Cell Biochem       Date:  2016-11-12       Impact factor: 3.396

3.  Determination of pentraxin 3 levels in cerebrospinal fluid during central nervous system infections.

Authors:  Marta Zatta; Stefano Di Bella; Barbara Bottazzi; Francesca Rossi; Pierlanfranco D'Agaro; Ludovica Segat; Massimiliano Fabbiani; Alberto Mantovani; Roberto Luzzati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-08       Impact factor: 3.267

Review 4.  Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.

Authors:  Marijn M Speeckaert; Reinhart Speeckaert; Juan J Carrero; Raymond Vanholder; Joris R Delanghe
Journal:  J Clin Immunol       Date:  2013-02-27       Impact factor: 8.317

Review 5.  Pentraxin 3 as a prognostic biomarker in patients with systemic inflammation or infection.

Authors:  Siguan Liu; Xin Qu; Feng Liu; Chunting Wang
Journal:  Mediators Inflamm       Date:  2014-11-03       Impact factor: 4.711

6.  PTX3 in serum induces renal mesangial cell proliferation but has no effect on apoptosis.

Authors:  Danhuan Zhang; Minhui Xi; Lingyun Chen; Yanping Huang; Peiju Mao
Journal:  Exp Ther Med       Date:  2017-11-16       Impact factor: 2.447

7.  Enhanced neutrophil apoptosis accompanying myeloperoxidase release during hemodialysis.

Authors:  Taro Fukushi; Tae Yamamoto; Mai Yoshida; Emi Fujikura; Mariko Miyazaki; Masaaki Nakayama
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

8.  Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps.

Authors:  Kenji Daigo; Takao Hamakubo
Journal:  Front Immunol       Date:  2012-12-13       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.